CorMedix (CRMD) Other Non Operating Income (2011 - 2025)
CorMedix (CRMD) posted Other Non Operating Income of $75195.0 for Q4 2025, up 203.39% sequentially from -$72727.0 in Q3 2025, and down 86.52% YoY from $557806.0 in Q4 2024.
CorMedix (CRMD) Other Non Operating Income (2011 - 2025) Analysis & Trends
CorMedix has reported Other Non Operating Income for 12 years, with the latest figure at $75195.0 in Q4 2025.
- Quarterly Other Non Operating Income fell 86.52% year-over-year to $75195.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$51999.0 (down 105.1% YoY) and the FY2025 annual result came in at -$52000.0, down 110.02% from the prior year.
- Other Non Operating Income climbed to $75195.0 in Q4 2025 per CRMD's latest filing, from -$72727.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $557806.0 in Q4 2024 and troughed at -$72727.0 in Q3 2025.
- A 5-year average of $90377.2 and a median of -$1363.0 in 2021 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income surged 45323.94% in 2024, then sank 852.4% in 2025.
- Over 5 years, Other Non Operating Income stood at -$9526.0 in 2021, then soared by 3302.27% to $305048.0 in 2022, then tumbled by 99.6% to $1228.0 in 2023, then soared by 45323.94% to $557806.0 in 2024, then plunged by 86.52% to $75195.0 in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $75195.0, -$72727.0, and -$16295.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75,195.00 |
| Sep 30, 2025 | -72,727.00 |
| Jun 30, 2025 | -16,295.00 |
| Mar 31, 2025 | -38,172.00 |
| Dec 31, 2024 | 557,806.00 |
| Sep 30, 2024 | -33,325.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | -4,008.00 |
| Dec 31, 2023 | 1,228.00 |
| Sep 30, 2023 | -29,199.00 |
| Jun 30, 2023 | 530,964.00 |
| Mar 31, 2023 | 12,345.00 |
| Dec 31, 2022 | 305,048.00 |
| Sep 30, 2022 | 23,572.00 |
| Jun 30, 2022 | 18,232.00 |
| Mar 31, 2022 | -1,833.00 |
| Dec 31, 2021 | -9,526.00 |
| Sep 30, 2021 | -4,447.00 |
| Jun 30, 2021 | -893.00 |
| Mar 31, 2021 | -6,420.00 |